337 related articles for article (PubMed ID: 22471668)
1. Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research.
Jones HE; Chisolm MS; Jansson LM; Terplan M
Addiction; 2013 Feb; 108(2):233-47. PubMed ID: 22471668
[TBL] [Abstract][Full Text] [Related]
2. Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?
Stitzer ML
Addiction; 2013 Feb; 108(2):249-50. PubMed ID: 23331877
[No Abstract] [Full Text] [Related]
3. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
[TBL] [Abstract][Full Text] [Related]
4. Use of naltrexone in treating opioid use disorder in pregnancy.
Towers CV; Katz E; Weitz B; Visconti K
Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
[TBL] [Abstract][Full Text] [Related]
5. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Kakko J; Heilig M; Sarman I
Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
[TBL] [Abstract][Full Text] [Related]
7. Treatment of opioid dependence in the setting of pregnancy.
Young JL; Martin PR
Psychiatr Clin North Am; 2012 Jun; 35(2):441-60. PubMed ID: 22640765
[TBL] [Abstract][Full Text] [Related]
8. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.
Connery HS
Harv Rev Psychiatry; 2015; 23(2):63-75. PubMed ID: 25747920
[TBL] [Abstract][Full Text] [Related]
9. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
Kelty E; Hulse G
Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone in the treatment of opioid-dependent pregnant women: common ground.
Jones HE; Chisolm MS; Jansson LM; Terplan M
Addiction; 2013 Feb; 108(2):255-6. PubMed ID: 23331881
[No Abstract] [Full Text] [Related]
11. Naltrexone implant treatment for buprenorphine dependence--Mauritian case series.
Jhugroo A; Ellayah D; Norman A; Hulse G
J Psychopharmacol; 2014 Aug; 28(8):800-3. PubMed ID: 24695742
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
[TBL] [Abstract][Full Text] [Related]
13. ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy.
;
Obstet Gynecol; 2012 May; 119(5):1070-6. PubMed ID: 22525931
[TBL] [Abstract][Full Text] [Related]
14. A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls.
Kelty E; Hulse G
Drugs; 2017 Jul; 77(11):1199-1210. PubMed ID: 28536980
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
Debelak K; Morrone WR; O'Grady KE; Jones HE
Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
[TBL] [Abstract][Full Text] [Related]
16. Blocking endogenous opioids during development--do we understand the consequences?
White J
Addiction; 2013 Feb; 108(2):251-2. PubMed ID: 23331878
[No Abstract] [Full Text] [Related]
17. Infants Born to Opioid-Dependent Women in Ontario, 2002-2014.
Brogly SB; Turner S; Lajkosz K; Davies G; Newman A; Johnson A; Dow K
J Obstet Gynaecol Can; 2017 Mar; 39(3):157-165. PubMed ID: 28343557
[TBL] [Abstract][Full Text] [Related]
18. Chronic opioid use during pregnancy: maternal and fetal implications.
Stanhope TJ; Gill LA; Rose C
Clin Perinatol; 2013 Sep; 40(3):337-50. PubMed ID: 23972743
[TBL] [Abstract][Full Text] [Related]
19. Double trouble-pregnancy and antagonist treatment in opioid dependence; two contentious issues needing further consideration and research.
Clark N; Verster A
Addiction; 2013 Feb; 108(2):253-5. PubMed ID: 23331880
[No Abstract] [Full Text] [Related]
20. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
O'Connor AB; Collett A; Alto WA; O'Brien LM
J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
